0001181431-13-022092.txt : 20130412 0001181431-13-022092.hdr.sgml : 20130412 20130412161617 ACCESSION NUMBER: 0001181431-13-022092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130410 FILED AS OF DATE: 20130412 DATE AS OF CHANGE: 20130412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER GENETICS, INC CENTRAL INDEX KEY: 0001349929 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 043462475 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 BUSINESS PHONE: 201.528.9200 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 FORMER COMPANY: FORMER CONFORMED NAME: CANCER GENETICS INC DATE OF NAME CHANGE: 20060117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPPAJOHN JOHN CENTRAL INDEX KEY: 0000897464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35817 FILM NUMBER: 13758918 MAIL ADDRESS: STREET 1: 1660 WALT WHITMAN ROAD STREET 2: SUITE 105 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 rrd376774.xml FORM 4 X0306 4 2013-04-10 0 0001349929 CANCER GENETICS, INC CGIX 0000897464 PAPPAJOHN JOHN 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 1 0 0 0 Common Stock, par value $0.0001 per share 2013-04-10 4 P 0 175000 A 682546 D Common Stock, par value $0.0001 per share 2013-04-10 4 P 0 100000 A 782546 D Common Stock, par value $0.0001 per share 2013-04-10 4 P 0 200000 A 982546 D Common Stock, par value $0.0001 per share 2013-04-10 4 P 0 200000 A 1182546 D Common Stock, par value $0.0001 per share 2013-04-10 4 C 0 80686 A 1263232 D Convertible Note 10.00 2013-04-10 4 C 0 1750000 0 D Common Stock 175000 0 D Convertible Note 10.00 2013-04-10 4 C 0 1000000 0 D Common Stock 100000 0 D Convertible Note 10.00 2013-04-10 4 C 0 2000000 0 D Common Stock 200000 0 D Convertible Note 10.00 2013-04-10 4 C 0 2000000 0 D Common Stock 200000 0 D Series A-1 Convertible Preferred Stock 13.20 2013-04-10 4 C 0 377789 0 D Common Stock 80686 0 D The convertible note converted into shares of common stock of Cancer Genetics, Inc. (the "Company") upon consummation of the Company's initial public offering at a conversion price per share equal to the lesser of (i) $42.50 per share and (ii) the initial public offering price per share. The convertible note had no expiration date. The convertible note converted into shares of common stock of the Company upon consummation of the Company's initial public offering at a price per share equal to the initial public offering price per share. The convertible note had no expiration date. The shares of Series A-1 Convertible Preferred Stock automatically converted into 0.2136 share of common stock of the Company upon consummation of the Company's initial public offering. The shares of Series A-1 Convertible Preferred Stock had no expiration date. /s/ John Pappajohn by Elizabeth Czerepak, Attorney-in-Fact 2013-04-12 EX-24. 2 rrd338624_382546.htm POWER OF ATTORNEY rrd338624_382546.html
                               POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby authorizes
Elizabeth A. Czerepak, the Chief Financial Officer of Cancer Genetics, Inc. (the
"Company"), the undersigned's true and lawful attorney-in-fact to:

        (1)execute for and on behalf of the undersigned, in the undersigned's
        capacity as an officer and/or director of the Company, Forms 3, 4, and 5
        in accordance with Section 16(a) of the Securities Exchange Act of 1934,
        as amended, and the rules thereunder;

        (2)do and perform any and all acts for and on behalf of the undersigned
        which may be necessary or desirable to complete and execute any such
        Form 3, 4, or 5, complete and execute any amendment or amendments
        thereto, and timely file such form with the United States Securities and
        Exchange Commission and any stock exchange or similar authority; and

        (3)take any other action of any type whatsoever in connection with the
        foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such
        attorney-in-fact's discretion.

        The undersigned hereby grants to the foregoing attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's designated substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorney-in-fact, in serving in such capacity at the request
of the undersigned, is not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended, and the rules thereunder.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 11 day of February, 2013.

                                        /s/ John Pappajohn
                                        ------------------------------------
                                        Signature

                                        John Pappajohn
                                        ------------------------------------
                                        Name